| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 OTOP2 GRID1 GRID2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 8.79e-09 | 459 | 131 | 17 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 OTOP2 GRID1 GRID2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 6.24e-08 | 525 | 131 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 OTOP2 GRID1 GRID2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 6.41e-08 | 526 | 131 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | gated channel activity | GABRD GABRE CACNA1F CACNA2D1 GRID1 GRID2 RYR1 RYR3 SCN1A SCN10A SCNN1G KCNS2 TRPM8 | 3.14e-07 | 334 | 131 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SLC24A5 CACNA1F CACNA2D1 OTOP2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 4.25e-07 | 343 | 131 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | transporter activity | SLC24A5 GABRD GABRE ATP8B3 CACNA1F CACNA2D1 RHBDF2 ABCA13 OTOP2 GRID1 GRID2 ATP8B1 SLC7A7 SLC7A11 ATP10A SLC16A12 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 8.84e-07 | 1289 | 131 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 OTOP2 GRID1 GRID2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 1.73e-05 | 793 | 131 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium channel activity | 2.28e-05 | 52 | 131 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.36e-05 | 26 | 131 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 ABCA13 OTOP2 GRID1 GRID2 SLC7A7 SLC7A11 SLC16A12 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 2.74e-05 | 1180 | 131 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.13e-05 | 193 | 131 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity | 4.27e-05 | 2 | 131 | 2 | GO:0004365 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase [NAD(P)+] (phosphorylating) activity | 4.27e-05 | 2 | 131 | 2 | GO:0043891 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.78e-05 | 197 | 131 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A5 CACNA1F CACNA2D1 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 5.73e-05 | 465 | 131 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | sodium ion binding | 9.53e-05 | 14 | 131 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 OTOP2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 1.36e-04 | 758 | 131 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | floppase activity | 1.45e-04 | 16 | 131 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.09e-04 | 129 | 131 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC24A5 CACNA1F CACNA2D1 OTOP2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 2.49e-04 | 627 | 131 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.54e-04 | 4 | 131 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC24A5 CACNA1F CACNA2D1 OTOP2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 | 4.31e-04 | 664 | 131 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.87e-04 | 151 | 131 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.34e-04 | 57 | 131 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 6.30e-04 | 6 | 131 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.30e-04 | 6 | 131 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 6.42e-04 | 26 | 131 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.42e-04 | 26 | 131 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 6.49e-04 | 60 | 131 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 7.19e-04 | 27 | 131 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 8.02e-04 | 28 | 131 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 8.79e-04 | 65 | 131 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 8.79e-04 | 65 | 131 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.34e-04 | 171 | 131 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.08e-03 | 31 | 131 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.16e-03 | 70 | 131 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.17e-03 | 8 | 131 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 1.17e-03 | 8 | 131 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.29e-03 | 182 | 131 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.30e-03 | 33 | 131 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.36e-03 | 184 | 131 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.49e-03 | 9 | 131 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.50e-03 | 75 | 131 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.65e-03 | 77 | 131 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.86e-03 | 10 | 131 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 2.26e-03 | 11 | 131 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 2.81e-03 | 43 | 131 | 3 | GO:0004177 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 3.18e-03 | 13 | 131 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.41e-03 | 46 | 131 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.69e-03 | 14 | 131 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.27e-03 | 100 | 131 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.57e-03 | 51 | 131 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 5.45e-03 | 17 | 131 | 2 | GO:0072542 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.45e-03 | 17 | 131 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | flippase activity | 5.45e-03 | 17 | 131 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 5.98e-03 | 110 | 131 | 4 | GO:0008238 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 6.10e-03 | 18 | 131 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 6.79e-03 | 19 | 131 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 7.51e-03 | 20 | 131 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 7.51e-03 | 20 | 131 | 2 | GO:0019211 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 RELN OTOP2 GRID1 GRID2 SPG11 ATP8B1 ATP10A RYR1 RYR3 SPTBN4 HECW2 SCN1A GNB5 SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 TRIM13 CNTN1 | 5.18e-07 | 1374 | 132 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 RELN OTOP2 GRID1 GRID2 ATP8B1 ATP10A RYR1 RYR3 HECW2 SCN1A GNB5 SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 TRIM13 | 6.02e-07 | 1115 | 132 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.20e-06 | 36 | 132 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 2.31e-05 | 238 | 132 | 9 | GO:0050954 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 4.81e-05 | 62 | 132 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cell junction organization | ROCK2 GABRE CLDN18 RELN SLK MYO1C PCDHGC4 LAMA5 GRID1 GRID2 SPG11 SLC7A11 LRIT3 CLDN1 SPTBN4 SETD5 C1QC SEMA4A | 4.95e-05 | 974 | 132 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC24A5 CACNA1F CACNA2D1 SPG11 RYR1 RYR3 SPTBN4 HECW2 SCN1A GNB5 SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 TRIM13 CNTN1 | 6.94e-05 | 1000 | 132 | 18 | GO:0030001 |
| GeneOntologyBiologicalProcess | sodium ion transport | 7.10e-05 | 275 | 132 | 9 | GO:0006814 | |
| GeneOntologyBiologicalProcess | nerve development | 7.24e-05 | 109 | 132 | 6 | GO:0021675 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC24A5 GABRD GABRE CACNA1F CACNA2D1 OTOP2 RYR1 RYR3 HECW2 SCN1A GNB5 SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 TRIM13 | 8.60e-05 | 1017 | 132 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | GABRE CACNA1F CACNA2D1 RELN SPG11 ATP8B1 SPTBN4 HECW2 GNB5 SCN10A KCNS2 TRIM13 CNTN1 | 8.65e-05 | 577 | 132 | 13 | GO:0043269 |
| GeneOntologyBiologicalProcess | synapse organization | ROCK2 GABRE RELN PCDHGC4 LAMA5 GRID1 GRID2 SPG11 SLC7A11 LRIT3 SPTBN4 SETD5 C1QC SEMA4A | 1.29e-04 | 685 | 132 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of secondary metabolite biosynthetic process | 1.35e-04 | 16 | 132 | 3 | GO:1900376 | |
| GeneOntologyBiologicalProcess | regulation of melanin biosynthetic process | 1.35e-04 | 16 | 132 | 3 | GO:0048021 | |
| GeneOntologyBiologicalProcess | regulation of secondary metabolic process | 1.35e-04 | 16 | 132 | 3 | GO:0043455 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC24A5 CACNA1F CACNA2D1 OTOP2 SPG11 RYR1 RYR3 SPTBN4 HECW2 SCN1A GNB5 SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 TRIM13 CNTN1 | 1.44e-04 | 1157 | 132 | 19 | GO:0006812 |
| GeneOntologyBiologicalProcess | protein localization to membrane | ROCK2 RELN MYO1C RHBDF2 TM9SF4 LAMA5 SLC7A11 WDR19 SPTBN4 ACSL3 ARL5B PPP2R5A SEC62 LGI1 | 1.73e-04 | 705 | 132 | 14 | GO:0072657 |
| GeneOntologyBiologicalProcess | localization within membrane | ROCK2 RELN MYO1C RHBDF2 TM9SF4 LAMA5 SPG11 SLC7A11 WDR19 SPTBN4 ACSL3 ARL5B PPP2R5A SEC62 LGI1 | 1.83e-04 | 798 | 132 | 15 | GO:0051668 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.42e-04 | 87 | 132 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRD GABRE CACNA2D1 RELN GRID1 GRID2 SCN1A SCN8A SCN9A SCN10A TSPAN4 KCNS2 | 2.55e-04 | 559 | 132 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC24A5 CACNA1F CACNA2D1 OTOP2 RYR1 RYR3 HECW2 SCN1A GNB5 SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 TRIM13 | 2.73e-04 | 922 | 132 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.29e-04 | 93 | 132 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC24A5 CACNA1F CACNA2D1 OTOP2 RYR1 RYR3 HECW2 SCN1A GNB5 SCN8A SCN9A SCN10A SCNN1G KCNS2 TRPM8 TRIM13 | 3.46e-04 | 942 | 132 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.90e-04 | 208 | 132 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | transposable element silencing by mRNA destabilization | 4.01e-04 | 5 | 132 | 2 | GO:0141008 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.59e-04 | 153 | 132 | 6 | GO:0030048 | |
| GeneOntologyCellularComponent | transporter complex | GABRD GABRE ATP8B3 CACNA1F CACNA2D1 GRID2 ATP8B1 ATP10A RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 | 4.45e-07 | 550 | 133 | 16 | GO:1990351 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRD GABRE CACNA1F CACNA2D1 GRID2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 | 9.08e-07 | 378 | 133 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | sodium channel complex | 1.02e-06 | 29 | 133 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | CACNA1F CACNA2D1 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 | 2.69e-06 | 235 | 133 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.50e-06 | 17 | 133 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRD GABRE CACNA1F CACNA2D1 GRID2 RYR1 RYR3 SCN1A SCN8A SCN9A SCN10A SCNN1G KCNS2 | 3.01e-05 | 523 | 133 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | axon initial segment | 3.29e-05 | 29 | 133 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 8.71e-05 | 14 | 133 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | cilium | CACNA1F DYNC2H1 GRK4 AMBRA1 TTLL7 WDR19 DNAI1 RAB28 IFT88 PIK3C3 PROM2 GAPDHS CFAP57 TAS2R19 TAS2R30 USH2A | 1.91e-04 | 898 | 133 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | node of Ranvier | 2.65e-04 | 20 | 133 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | Z disc | 4.15e-04 | 151 | 133 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 4.45e-04 | 153 | 133 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | stereocilium membrane | 5.93e-04 | 6 | 133 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | I band | 6.84e-04 | 166 | 133 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.16e-03 | 405 | 133 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.21e-03 | 73 | 133 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRD GABRE CACNA2D1 GRID1 GRID2 SCN1A GNB5 SCN8A SCN10A C1QC CNTN1 | 1.27e-03 | 583 | 133 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | junctional membrane complex | 1.40e-03 | 9 | 133 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | non-motile cilium | 1.61e-03 | 196 | 133 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | stereocilium bundle | 1.63e-03 | 79 | 133 | 4 | GO:0032421 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.97e-03 | 139 | 133 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | motile cilium | 1.99e-03 | 355 | 133 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.00e-03 | 277 | 133 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | cell body fiber | 2.13e-03 | 11 | 133 | 2 | GO:0070852 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ROCK2 GABRD CACNA2D1 GAPDH LAMA5 GRID1 GRID2 PIK3C3 SCN8A SCN10A C1QC CNTN1 LGI1 | 2.15e-03 | 817 | 133 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | main axon | 2.52e-03 | 89 | 133 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 2.58e-03 | 43 | 133 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.07e-03 | 223 | 133 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.13e-03 | 46 | 133 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ATP8B3 DIPK1C RHBDF2 DOLK ATP10A LRIT3 RYR1 RYR3 ACSL3 KSR1 CEPT1 ERAP2 PGAP1 SEC62 DISP3 TRPM8 TRIM13 | 3.49e-03 | 1293 | 133 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | ciliary tip | 3.53e-03 | 48 | 133 | 3 | GO:0097542 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 3.53e-03 | 48 | 133 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ATP8B3 DIPK1C RHBDF2 DOLK ATP10A LRIT3 RYR1 RYR3 ACSL3 KSR1 CEPT1 ERAP2 PGAP1 SEC62 DISP3 TRPM8 TRIM13 | 3.65e-03 | 1299 | 133 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.01e-03 | 164 | 133 | 5 | GO:0098982 | |
| HumanPheno | Focal clonic seizure | 6.39e-06 | 42 | 58 | 6 | HP:0002266 | |
| HumanPheno | Focal automatism seizure | 7.00e-06 | 12 | 58 | 4 | HP:0032898 | |
| MousePheno | abnormal hair shaft melanin granule shape | 5.14e-07 | 3 | 113 | 3 | MP:0009273 | |
| MousePheno | abnormal hair follicle morphology | 2.62e-05 | 148 | 113 | 8 | MP:0000377 | |
| MousePheno | abnormal posture | 2.71e-05 | 243 | 113 | 10 | MP:0001504 | |
| MousePheno | abnormal cerebellar granule cell morphology | 2.98e-05 | 45 | 113 | 5 | MP:0004098 | |
| MousePheno | abnormal pilosebaceous unit morphology | 4.21e-05 | 205 | 113 | 9 | MP:0030572 | |
| MousePheno | Purkinje cell degeneration | 4.84e-05 | 81 | 113 | 6 | MP:0000876 | |
| MousePheno | abnormal brain development | RELN SLK DYNC2H1 LAMA5 AMBRA1 MECOM GRID2 SLC7A7 SFMBT2 DNAI1 IFT88 PGAP1 SCN8A EML1 CFAP57 LGI1 | 5.26e-05 | 638 | 113 | 16 | MP:0000913 |
| MousePheno | abnormal cerebellar granule layer morphology | 6.35e-05 | 85 | 113 | 6 | MP:0000886 | |
| MousePheno | neurodegeneration | CACNA1F RELN NAGLU GRID1 GRID2 SPG11 ATP8B1 SPTBN4 RAB28 SACS SCN8A USH2A LGI1 | 1.02e-04 | 468 | 113 | 13 | MP:0002229 |
| MousePheno | abnormal behavioral response to anesthetic | 1.07e-04 | 12 | 113 | 3 | MP:0009777 | |
| MousePheno | hearing/vestibular/ear phenotype | SLC24A5 MYO1C NAGLU LAMA5 MECOM GRID1 GRID2 ATP8B1 SLC7A11 LYST WDR19 SPTBN4 LRIG2 TYRP1 IFT88 SETD5 PGAP1 SCN8A USH2A | 1.09e-04 | 905 | 113 | 19 | MP:0005377 |
| MousePheno | muscle spasm | 1.21e-04 | 60 | 113 | 5 | MP:0000743 | |
| MousePheno | abnormal coat appearance | SLC24A5 RELN RHBDF2 DSG3 NAGLU SLC7A11 LYST CLDN1 LRIG2 TYRP1 KSR1 RAB28 PPP2R5A IFT88 SETD5 SEC62 EML1 | 1.54e-04 | 774 | 113 | 17 | MP:0001510 |
| MousePheno | muscle twitch | 1.65e-04 | 64 | 113 | 5 | MP:0009046 | |
| MousePheno | absence seizures | 1.75e-04 | 35 | 113 | 4 | MP:0003216 | |
| MousePheno | decreased Purkinje cell number | 2.05e-04 | 67 | 113 | 5 | MP:0000880 | |
| MousePheno | abnormal hair shaft melanin granule morphology | 2.18e-04 | 15 | 113 | 3 | MP:0008731 | |
| MousePheno | abnormal Purkinje cell number | 2.35e-04 | 69 | 113 | 5 | MP:0000878 | |
| MousePheno | abnormal Purkinje cell morphology | 2.48e-04 | 204 | 113 | 8 | MP:0000877 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | SLC24A5 CACNA2D1 RELN DOLK MECOM GRID2 SPG11 ATP8B1 SLC7A7 LYST RYR1 GDE1 SPTBN4 KLHDC1 SACS SETD5 SCN1A SCN8A SCN9A SCN10A C1QC TRPM8 EML1 MMP16 ENPEP | 2.79e-04 | 1486 | 113 | 25 | MP:0002067 |
| MousePheno | abnormal cerebellar layer morphology | 2.80e-04 | 263 | 113 | 9 | MP:0009956 | |
| MousePheno | nonconvulsive seizures | 2.96e-04 | 40 | 113 | 4 | MP:0000948 | |
| MousePheno | neuron degeneration | CACNA1F RELN NAGLU GRID1 GRID2 SPG11 ATP8B1 RAB28 SACS SCN8A USH2A | 3.22e-04 | 391 | 113 | 11 | MP:0003224 |
| MousePheno | abnormal hair shaft morphology | 3.47e-04 | 75 | 113 | 5 | MP:0003809 | |
| MousePheno | abnormal ciliary body pigmentation | 3.85e-04 | 4 | 113 | 2 | MP:0005101 | |
| MousePheno | abnormal skin adnexa morphology | SLC24A5 RELN RHBDF2 DSG3 TM9SF4 NAGLU LAMA5 SLC7A11 LYST CLDN1 RYR1 LRIG2 TYRP1 KSR1 RAB28 PPP2R5A IFT88 SETD5 PROM2 SEC62 C1QC EML1 TRIM13 | 3.92e-04 | 1341 | 113 | 23 | MP:0010678 |
| MousePheno | abnormal cerebellar Purkinje cell layer | 4.11e-04 | 220 | 113 | 8 | MP:0000875 | |
| MousePheno | abnormal ear morphology | SLC24A5 NAGLU LAMA5 MECOM GRID1 ATP8B1 LYST WDR19 TYRP1 IFT88 PGAP1 USH2A | 4.13e-04 | 470 | 113 | 12 | MP:0002102 |
| MousePheno | impaired balance | 4.41e-04 | 121 | 113 | 6 | MP:0001525 | |
| MousePheno | abnormal coat/ hair morphology | SLC24A5 RELN RHBDF2 DSG3 NAGLU SLC7A11 LYST CLDN1 LRIG2 TYRP1 KSR1 RAB28 PPP2R5A IFT88 SETD5 SEC62 EML1 | 4.86e-04 | 854 | 113 | 17 | MP:0000367 |
| MousePheno | abnormal eye electrophysiology | 5.21e-04 | 228 | 113 | 8 | MP:0005551 | |
| MousePheno | abnormal hindbrain morphology | RELN NAGLU AMBRA1 GRID2 SPG11 LYST SPTBN4 SACS SETD5 SCN8A CNTN1 LGI1 | 5.46e-04 | 485 | 113 | 12 | MP:0000841 |
| MousePheno | abnormal truncus arteriosus septation | 5.87e-04 | 84 | 113 | 5 | MP:0010454 | |
| MousePheno | impaired behavioral response to anesthetic | 6.37e-04 | 5 | 113 | 2 | MP:0009778 | |
| Domain | Ion_trans_dom | 1.02e-07 | 114 | 130 | 9 | IPR005821 | |
| Domain | Ion_trans | 1.02e-07 | 114 | 130 | 9 | PF00520 | |
| Domain | Na_channel_asu | 4.56e-07 | 10 | 130 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 4.56e-07 | 10 | 130 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 4.56e-07 | 10 | 130 | 4 | PF06512 | |
| Domain | Channel_four-helix_dom | 2.75e-06 | 57 | 130 | 6 | IPR027359 | |
| Domain | - | 2.75e-06 | 57 | 130 | 6 | 1.20.120.350 | |
| Domain | Na_trans_cytopl | 6.49e-06 | 6 | 130 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 6.49e-06 | 6 | 130 | 3 | IPR024583 | |
| Domain | IQ_motif_EF-hand-BS | 3.91e-05 | 90 | 130 | 6 | IPR000048 | |
| Domain | IQ | 4.70e-05 | 93 | 130 | 6 | PS50096 | |
| Domain | Gp_dh_C | 4.81e-05 | 2 | 130 | 2 | PF02800 | |
| Domain | GlycerAld_3-P_DH_AS | 4.81e-05 | 2 | 130 | 2 | IPR020830 | |
| Domain | GlycerAld/Erythrose_P_DH | 4.81e-05 | 2 | 130 | 2 | IPR020831 | |
| Domain | GlycerAld_3-P_DH_NAD(P)-bd | 4.81e-05 | 2 | 130 | 2 | IPR020828 | |
| Domain | GlycerAld_3-P_DH_cat | 4.81e-05 | 2 | 130 | 2 | IPR020829 | |
| Domain | GAPDH | 4.81e-05 | 2 | 130 | 2 | PS00071 | |
| Domain | Gp_dh_N | 4.81e-05 | 2 | 130 | 2 | SM00846 | |
| Domain | Glyceraldehyde-3-P_DH_1 | 4.81e-05 | 2 | 130 | 2 | IPR006424 | |
| Domain | Gp_dh_N | 4.81e-05 | 2 | 130 | 2 | PF00044 | |
| Domain | P_typ_ATPase_c | 1.13e-04 | 14 | 130 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.13e-04 | 14 | 130 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.13e-04 | 14 | 130 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.13e-04 | 14 | 130 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.13e-04 | 14 | 130 | 3 | PF16209 | |
| Domain | IQ | 1.36e-04 | 71 | 130 | 5 | PF00612 | |
| Domain | Ryanodine_rcpt | 1.44e-04 | 3 | 130 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.44e-04 | 3 | 130 | 2 | IPR009460 | |
| Domain | RyR | 1.44e-04 | 3 | 130 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.44e-04 | 3 | 130 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.44e-04 | 3 | 130 | 2 | IPR013333 | |
| Domain | IQ | 2.54e-04 | 81 | 130 | 5 | SM00015 | |
| Domain | PP2A_B56 | 4.74e-04 | 5 | 130 | 2 | IPR002554 | |
| Domain | B56 | 4.74e-04 | 5 | 130 | 2 | PF01603 | |
| Domain | RIH_assoc-dom | 7.08e-04 | 6 | 130 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.08e-04 | 6 | 130 | 2 | PF08709 | |
| Domain | RIH_assoc | 7.08e-04 | 6 | 130 | 2 | PF08454 | |
| Domain | RIH_dom | 7.08e-04 | 6 | 130 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.08e-04 | 6 | 130 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.08e-04 | 6 | 130 | 2 | IPR015925 | |
| Domain | - | 7.08e-04 | 6 | 130 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.08e-04 | 6 | 130 | 2 | PF01365 | |
| Domain | PIP49_C | 7.08e-04 | 6 | 130 | 2 | PF12260 | |
| Domain | FAM69_kinase_dom | 7.08e-04 | 6 | 130 | 2 | IPR022049 | |
| Domain | TAS2R | 7.62e-04 | 26 | 130 | 3 | PF05296 | |
| Domain | T2R | 7.62e-04 | 26 | 130 | 3 | IPR007960 | |
| Domain | ERAP1-like_C_dom | 1.31e-03 | 8 | 130 | 2 | IPR024571 | |
| Domain | PI3K_C2 | 1.31e-03 | 8 | 130 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 1.31e-03 | 8 | 130 | 2 | IPR002420 | |
| Domain | ERAP1_C | 1.31e-03 | 8 | 130 | 2 | PF11838 | |
| Domain | PI3K_C2 | 1.31e-03 | 8 | 130 | 2 | PF00792 | |
| Domain | PI3K_C2 | 1.31e-03 | 8 | 130 | 2 | PS51547 | |
| Domain | - | 1.41e-03 | 32 | 130 | 3 | 3.40.1110.10 | |
| Domain | - | 1.41e-03 | 32 | 130 | 3 | 2.70.150.10 | |
| Domain | PI3Ka | 1.68e-03 | 9 | 130 | 2 | PF00613 | |
| Domain | PI3Ka | 1.68e-03 | 9 | 130 | 2 | SM00145 | |
| Domain | - | 1.68e-03 | 9 | 130 | 2 | 1.25.40.70 | |
| Domain | ATPase_P-typ_cyto_domN | 1.83e-03 | 35 | 130 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.99e-03 | 36 | 130 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.99e-03 | 36 | 130 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.99e-03 | 36 | 130 | 3 | PS00154 | |
| Domain | MIR | 2.09e-03 | 10 | 130 | 2 | PF02815 | |
| Domain | MIR_motif | 2.09e-03 | 10 | 130 | 2 | IPR016093 | |
| Domain | PI_Kinase | 2.09e-03 | 10 | 130 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 2.09e-03 | 10 | 130 | 2 | IPR001263 | |
| Domain | MIR | 2.09e-03 | 10 | 130 | 2 | PS50919 | |
| Domain | MIR | 2.09e-03 | 10 | 130 | 2 | SM00472 | |
| Domain | Hydrolase_3 | 2.09e-03 | 10 | 130 | 2 | PF08282 | |
| Domain | PIK_HELICAL | 2.09e-03 | 10 | 130 | 2 | PS51545 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.15e-03 | 37 | 130 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.15e-03 | 37 | 130 | 3 | PF00122 | |
| Domain | WD40 | 2.26e-03 | 259 | 130 | 7 | PF00400 | |
| Domain | - | 2.32e-03 | 333 | 130 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.41e-03 | 335 | 130 | 8 | IPR015943 | |
| Domain | WD40 | 2.74e-03 | 268 | 130 | 7 | SM00320 | |
| Domain | WD40_repeat | 2.97e-03 | 272 | 130 | 7 | IPR001680 | |
| Domain | Peptidase_M1 | 3.03e-03 | 12 | 130 | 2 | IPR001930 | |
| Domain | WD_REPEATS_1 | 3.35e-03 | 278 | 130 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.42e-03 | 279 | 130 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.42e-03 | 279 | 130 | 7 | PS50294 | |
| Domain | AA_permease_2 | 3.57e-03 | 13 | 130 | 2 | PF13520 | |
| Domain | Peptidase_M1_N | 3.57e-03 | 13 | 130 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 3.57e-03 | 13 | 130 | 2 | PF01433 | |
| Domain | AA/rel_permease1 | 3.57e-03 | 13 | 130 | 2 | IPR002293 | |
| Domain | PI3/4_kinase_CS | 4.76e-03 | 15 | 130 | 2 | IPR018936 | |
| Domain | WD40_repeat_dom | 4.80e-03 | 297 | 130 | 7 | IPR017986 | |
| Domain | - | 5.41e-03 | 16 | 130 | 2 | 1.10.1070.11 | |
| Domain | Laminin_N | 5.41e-03 | 16 | 130 | 2 | IPR008211 | |
| Domain | PI3Kc | 5.41e-03 | 16 | 130 | 2 | SM00146 | |
| Domain | LamNT | 5.41e-03 | 16 | 130 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 5.41e-03 | 16 | 130 | 2 | PS51117 | |
| Domain | Laminin_N | 5.41e-03 | 16 | 130 | 2 | PF00055 | |
| Domain | Gal_mutarotase_SF_dom | 6.11e-03 | 17 | 130 | 2 | IPR011013 | |
| Domain | Lig_chan-Glu_bd | 6.84e-03 | 18 | 130 | 2 | PF10613 | |
| Domain | PI3_PI4_kinase | 6.84e-03 | 18 | 130 | 2 | PF00454 | |
| Domain | Glu/Gly-bd | 6.84e-03 | 18 | 130 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.84e-03 | 18 | 130 | 2 | SM00918 | |
| Domain | PI3_4_KINASE_1 | 6.84e-03 | 18 | 130 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.84e-03 | 18 | 130 | 2 | PS00916 | |
| Domain | Iontro_rcpt | 6.84e-03 | 18 | 130 | 2 | IPR001320 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.89e-06 | 31 | 104 | 5 | M877 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 7.55e-05 | 31 | 104 | 4 | MM15691 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 8.58e-05 | 32 | 104 | 4 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.70e-04 | 121 | 104 | 6 | M872 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.22e-04 | 176 | 104 | 7 | MM15718 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 3.60e-04 | 46 | 104 | 4 | M46450 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 3.91e-04 | 47 | 104 | 4 | M42524 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.97e-04 | 130 | 104 | 6 | M27454 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.08e-04 | 183 | 104 | 7 | M997 | |
| Pubmed | 9.52e-10 | 13 | 133 | 5 | 15123669 | ||
| Pubmed | 3.05e-09 | 6 | 133 | 4 | 16029194 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.05e-09 | 6 | 133 | 4 | 23652591 | |
| Pubmed | 2.54e-08 | 9 | 133 | 4 | 16382098 | ||
| Pubmed | Identification of rat EMAP, a delta-glutamate receptor binding protein. | 5.47e-08 | 3 | 133 | 3 | 11829466 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.84e-08 | 139 | 133 | 8 | 16985003 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 22260870 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ROCK2 CACNA2D1 GAPDH TM9SF4 TUT7 NAGLU LAMA5 COLGALT1 SLC7A11 LRP1B GDE1 DIPK2A LRIG2 MRC2 PGAP1 SEC62 TRIM13 CD276 | 8.03e-07 | 1201 | 133 | 18 | 35696571 |
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 23711479 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 2230805 | ||
| Pubmed | Peripheral macrophage abnormalities in mutant mice with spinocerebellar degeneration. | 6.43e-06 | 10 | 133 | 3 | 1565842 | |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 8.64e-06 | 72 | 133 | 5 | 25917818 | |
| Pubmed | The IFT-A complex regulates Shh signaling through cilia structure and membrane protein trafficking. | 8.82e-06 | 11 | 133 | 3 | 22689656 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19524556 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.45e-05 | 2 | 133 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.45e-05 | 2 | 133 | 2 | 26410685 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9489997 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 1.45e-05 | 2 | 133 | 2 | 12640042 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 14592949 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 7628014 | ||
| Pubmed | Expression of a glyceraldehyde 3-phosphate dehydrogenase gene specific to mouse spermatogenic cells. | 1.45e-05 | 2 | 133 | 2 | 1375514 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31943325 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9584610 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9799464 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 8270621 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.45e-05 | 2 | 133 | 2 | 27174182 | |
| Pubmed | Glutamate receptors of the delta family are widely expressed in the adult brain. | 1.45e-05 | 2 | 133 | 2 | 25001082 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29087386 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.45e-05 | 2 | 133 | 2 | 17118445 | |
| Pubmed | Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. | 1.45e-05 | 2 | 133 | 2 | 3170585 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 1.45e-05 | 2 | 133 | 2 | 11500519 | |
| Pubmed | Mutagenic insertion and chromosome engineering resource (MICER). | 1.45e-05 | 2 | 133 | 2 | 15235602 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12165290 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 1.45e-05 | 2 | 133 | 2 | 16111501 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12565913 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9192302 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 37944084 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 7556644 | ||
| Pubmed | Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease. | 1.45e-05 | 2 | 133 | 2 | 16832079 | |
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 1.45e-05 | 2 | 133 | 2 | 15894801 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 33411788 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31625608 | ||
| Pubmed | GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons. | 1.45e-05 | 2 | 133 | 2 | 28696429 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9817784 | ||
| Pubmed | Glyceraldehyde-3-phosphate dehydrogenase from human tissues. | 1.45e-05 | 2 | 133 | 2 | 7144574 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 10742052 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 15507493 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 1.45e-05 | 2 | 133 | 2 | 37665666 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17881658 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 16324157 | ||
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 1.52e-05 | 13 | 133 | 3 | 11015572 | |
| Pubmed | 1.52e-05 | 13 | 133 | 3 | 35904071 | ||
| Pubmed | 1.52e-05 | 13 | 133 | 3 | 15938754 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GABRE RHBDF2 SCAF8 TM9SF4 ATP8B1 ATP10A SFMBT2 GDE1 SPTBN4 RAB28 PTPRB SETD5 PIK3C3 PROM2 ANKAR TSPAN4 MMP16 AFF4 | 1.57e-05 | 1489 | 133 | 18 | 28611215 |
| Pubmed | ROCK2 DYNC2H1 ATP10A USP20 LRIG2 SACS DSTYK DISP3 KCNS2 CDC5L | 2.13e-05 | 493 | 133 | 10 | 15368895 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CACNA2D1 SLK MYO1C GAPDH DSG3 DYNC2H1 NAGLU LAMA5 GRID1 RYR1 TGFBR3 PROM2 SCN10A ENPEP | 3.68e-05 | 1016 | 133 | 14 | 19056867 |
| Pubmed | [Under hypoxia condition contactin-1 regulates migration of MKN45 cells through RhoA pathway]. | 4.34e-05 | 3 | 133 | 2 | 25916117 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18403125 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 11171121 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 10234023 | ||
| Pubmed | The cell and molecular basis of mechanical, cold, and inflammatory pain. | 4.34e-05 | 3 | 133 | 2 | 18669863 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 33895391 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 38663398 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 7876312 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 22449024 | ||
| Pubmed | Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. | 4.34e-05 | 3 | 133 | 2 | 22875917 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 16033895 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 27816501 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 38999942 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 22948152 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 20133873 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 4.34e-05 | 3 | 133 | 2 | 10788707 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 20301709 | ||
| Pubmed | Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain. | 4.34e-05 | 3 | 133 | 2 | 29497094 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 4.34e-05 | 3 | 133 | 2 | 7621815 | |
| Pubmed | Teleost B7 expressed on monocytes regulates T cell responses. | 4.34e-05 | 3 | 133 | 2 | 19454675 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 26182346 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 4.34e-05 | 3 | 133 | 2 | 10473538 | |
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 4.34e-05 | 3 | 133 | 2 | 31054517 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 11807096 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18313230 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 12368162 | ||
| Pubmed | Testosterone-androgen receptor: The steroid link inhibiting TRPM8-mediated cold sensitivity. | 4.34e-05 | 3 | 133 | 2 | 32277850 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18434746 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 19195685 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 4.34e-05 | 3 | 133 | 2 | 9204703 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 19699781 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 21881589 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 32845893 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 12802074 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 4.34e-05 | 3 | 133 | 2 | 12213830 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 28518218 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 28074005 | ||
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 4.34e-05 | 3 | 133 | 2 | 24704313 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 9242641 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 15314237 | ||
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 4.34e-05 | 3 | 133 | 2 | 28117367 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 17928448 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 25239916 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 4.34e-05 | 3 | 133 | 2 | 30554136 | |
| Interaction | SCN11A interactions | 2.20e-06 | 15 | 131 | 4 | int:SCN11A | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 9.61e-08 | 9 | 97 | 4 | 1203 | |
| GeneFamily | Glutamate ionotropic receptor delta type subunits | 2.85e-05 | 2 | 97 | 2 | 1202 | |
| GeneFamily | ATPase phospholipid transporting | 6.50e-05 | 15 | 97 | 3 | 1210 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.52e-05 | 3 | 97 | 2 | 287 | |
| GeneFamily | WD repeat domain containing | 5.25e-04 | 262 | 97 | 7 | 362 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 7.81e-04 | 8 | 97 | 2 | 831 | |
| GeneFamily | Taste 2 receptors | 1.19e-03 | 39 | 97 | 3 | 1162 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.86e-03 | 15 | 97 | 2 | 696 | |
| GeneFamily | Aminopeptidases|CD molecules | 3.68e-03 | 17 | 97 | 2 | 104 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 4.59e-03 | 19 | 97 | 2 | 563 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.33e-05 | 202 | 129 | 8 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#5_top-relative-expression-ranked_200 | 5.99e-05 | 13 | 129 | 3 | gudmap_developingKidney_e13.5_podocyte cells_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 7.69e-05 | 116 | 129 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.36e-05 | 234 | 129 | 8 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_200 | 9.84e-05 | 175 | 129 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#3_top-relative-expression-ranked_500 | 1.16e-04 | 16 | 129 | 3 | gudmap_developingKidney_e15.5_Endothelial cells_500_k3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F RELN ABCA13 GRID1 LRP1B RYR3 SCN9A DISP3 USH2A CNTN1 | 2.24e-10 | 184 | 133 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F RELN ABCA13 GRID1 LRP1B RYR3 SCN9A DISP3 USH2A CNTN1 | 2.24e-10 | 184 | 133 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F RELN ABCA13 GRID1 LRP1B RYR3 SCN9A DISP3 USH2A CNTN1 | 2.24e-10 | 184 | 133 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-09 | 162 | 133 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 145 | 133 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-08 | 158 | 133 | 8 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-08 | 158 | 133 | 8 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 183 | 133 | 7 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 183 | 133 | 7 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 184 | 133 | 7 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 186 | 133 | 7 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 186 | 133 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 191 | 133 | 7 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 192 | 133 | 7 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-06 | 193 | 133 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-06 | 193 | 133 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-06 | 194 | 133 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 133 | 7 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 133 | 7 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-06 | 197 | 133 | 7 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-06 | 198 | 133 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-06 | 199 | 133 | 7 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 199 | 133 | 7 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 199 | 133 | 7 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 137 | 133 | 6 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 137 | 133 | 6 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 4.95e-06 | 145 | 133 | 6 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 4.95e-06 | 145 | 133 | 6 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.15e-06 | 146 | 133 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-06 | 155 | 133 | 6 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-06 | 155 | 133 | 6 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-06 | 155 | 133 | 6 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.09e-06 | 158 | 133 | 6 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 169 | 133 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 170 | 133 | 6 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 172 | 133 | 6 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 173 | 133 | 6 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-05 | 175 | 133 | 6 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 178 | 133 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.70e-05 | 180 | 133 | 6 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 181 | 133 | 6 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 133 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 133 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-05 | 182 | 133 | 6 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.86e-05 | 183 | 133 | 6 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 183 | 133 | 6 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 183 | 133 | 6 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-05 | 183 | 133 | 6 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 183 | 133 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 188 | 133 | 6 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 188 | 133 | 6 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 189 | 133 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 189 | 133 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 190 | 133 | 6 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 190 | 133 | 6 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 190 | 133 | 6 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 190 | 133 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.30e-05 | 190 | 133 | 6 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 190 | 133 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 2.37e-05 | 191 | 133 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.37e-05 | 191 | 133 | 6 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 191 | 133 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 2.37e-05 | 191 | 133 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 192 | 133 | 6 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 192 | 133 | 6 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 193 | 133 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 193 | 133 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 193 | 133 | 6 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 193 | 133 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-05 | 193 | 133 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 193 | 133 | 6 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.67e-05 | 195 | 133 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.67e-05 | 195 | 133 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.74e-05 | 196 | 133 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.80e-05 | 118 | 133 | 5 | e5202fadb3f9d91e56337ddad1666196ec748d87 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 197 | 133 | 6 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | Non-neuronal-Postmitotic-Microglia-Microglia-8|World / Primary Cells by Cluster | 2.82e-05 | 197 | 133 | 6 | 93bce9741dec4e60dd470acca87cd4c8074f8876 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-05 | 198 | 133 | 6 | 7f728ca6d5317890c6fcde3ce6c10c0970d49a05 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.90e-05 | 198 | 133 | 6 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid-Microglia|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-05 | 198 | 133 | 6 | c0d33629438504a1545e07f0e5af2e76f50fd55b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-05 | 198 | 133 | 6 | 2b93995f66c7352acc25d6c71d025b847881dacd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-05 | 198 | 133 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.99e-05 | 199 | 133 | 6 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 133 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-05 | 199 | 133 | 6 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-05 | 199 | 133 | 6 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-SPP1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 199 | 133 | 6 | d94cf750599366061066074e8007d707adf6fc5a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-05 | 200 | 133 | 6 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-05 | 200 | 133 | 6 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-05 | 200 | 133 | 6 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-05 | 200 | 133 | 6 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 139 | 133 | 5 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 6.13e-05 | 139 | 133 | 5 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 139 | 133 | 5 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.79e-05 | 150 | 133 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 153 | 133 | 5 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 153 | 133 | 5 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-04 | 157 | 133 | 5 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 157 | 133 | 5 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| Computational | Neighborhood of IFNA1 | 1.77e-04 | 205 | 83 | 8 | MORF_IFNA1 | |
| Computational | Neighborhood of CAMK4 | 3.82e-04 | 290 | 83 | 9 | MORF_CAMK4 | |
| Computational | Neighborhood of MLLT10 | 5.14e-04 | 302 | 83 | 9 | MORF_MLLT10 | |
| Computational | Neighborhood of MLF1 | 5.47e-04 | 87 | 83 | 5 | GNF2_MLF1 | |
| Computational | Neighborhood of PTPRB | 7.44e-04 | 254 | 83 | 8 | MORF_PTPRB | |
| Computational | Neighborhood of RAD51L3 | CACNA2D1 CPB2 ATP8B1 ST8SIA1 USP20 RYR1 RYR3 PPP2R5B PTPRB LGI1 | 7.60e-04 | 387 | 83 | 10 | MORF_RAD51L3 |
| Computational | Neighborhood of MAGEA8 | 8.66e-04 | 260 | 83 | 8 | MORF_MAGEA8 | |
| Computational | Neighborhood of SUPT3H | 9.27e-04 | 328 | 83 | 9 | MORF_SUPT3H | |
| Computational | Neighborhood of ATF2 | 9.68e-04 | 330 | 83 | 9 | MORF_ATF2 | |
| Computational | Neighborhood of MDM2 | 1.36e-03 | 279 | 83 | 8 | MORF_MDM2 | |
| Computational | Neighborhood of FSHR | 1.36e-03 | 279 | 83 | 8 | MORF_FSHR | |
| Drug | gabapentin | GABRD GABRE CACNA1F CACNA2D1 GRID1 GRID2 RYR1 RYR3 SCN9A SCN10A SCNN1G | 4.33e-09 | 169 | 132 | 11 | CID000003446 |
| Drug | riluzole | GABRD GABRE CACNA1F CACNA2D1 GRID1 GRID2 RYR1 RYR3 SCN9A SCN10A SCNN1G | 5.88e-09 | 174 | 132 | 11 | CID000005070 |
| Drug | T2755 | 1.83e-07 | 71 | 132 | 7 | CID000005514 | |
| Drug | ketamine | GABRD GABRE CACNA2D1 GRID1 GRID2 F5 RYR1 SCN9A SCN10A SCNN1G CNTN1 | 3.85e-07 | 262 | 132 | 11 | CID000003821 |
| Drug | isoflurane | GABRD GABRE ICOSLG CACNA2D1 GRID1 GRID2 RYR1 RYR3 SCN9A SCN10A SCNN1G | 7.17e-07 | 279 | 132 | 11 | CID000003763 |
| Drug | isradipine | 1.92e-06 | 100 | 132 | 7 | CID000003784 | |
| Drug | flecainide | 3.56e-06 | 71 | 132 | 6 | CID000003355 | |
| Drug | chloro-m-cresol | 3.76e-06 | 6 | 132 | 3 | CID000012008 | |
| Drug | lamotrigine | 5.18e-06 | 116 | 132 | 7 | CID000003878 | |
| Drug | Azumoleno | 6.55e-06 | 7 | 132 | 3 | CID000056259 | |
| Drug | CHEBI:564108 | 6.55e-06 | 7 | 132 | 3 | CID006400637 | |
| Drug | spiradoline | 6.88e-06 | 46 | 132 | 5 | CID000005620 | |
| Drug | bepridil | 8.93e-06 | 126 | 132 | 7 | CID000002351 | |
| Drug | AC1NT1AF | 1.24e-05 | 25 | 132 | 4 | CID005322157 | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.27e-05 | 185 | 132 | 8 | 5364_DN | |
| Drug | propofol | 1.61e-05 | 191 | 132 | 8 | CID000004943 | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A | 1.67e-05 | 192 | 132 | 8 | 2572_UP | |
| Drug | AC1L1MOZ | 1.71e-05 | 27 | 132 | 4 | CID000031958 | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; HL60; HG-U133A | 2.16e-05 | 199 | 132 | 8 | 1581_UP | |
| Drug | gadolinium | 2.16e-05 | 199 | 132 | 8 | CID000023982 | |
| Drug | procaine | 3.15e-05 | 153 | 132 | 7 | CID000004914 | |
| Drug | platensimycin | 3.26e-05 | 63 | 132 | 5 | CID006857724 | |
| Drug | 2-aza-9,10-anthraquinone | 3.34e-05 | 2 | 132 | 2 | CID000100650 | |
| Drug | alpha-cyano-3-hydroxycinnamic acid | 3.34e-05 | 2 | 132 | 2 | CID000002101 | |
| Drug | beta-(2-furyl)acryloyl phosphate | 3.34e-05 | 2 | 132 | 2 | CID006439216 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 3.34e-05 | 2 | 132 | 2 | ctd:C005147 | |
| Drug | alpha-chlorohydrin-1-phosphate | 3.34e-05 | 2 | 132 | 2 | CID000208040 | |
| Drug | Sm35 | 3.34e-05 | 2 | 132 | 2 | CID000486051 | |
| Drug | tetrahydropentalenolactone | 3.34e-05 | 2 | 132 | 2 | CID000190858 | |
| Drug | 1-chloro-3-hydroxyacetone | 3.34e-05 | 2 | 132 | 2 | CID000090494 | |
| Drug | 2'-hydroxy-3,4,4',5,6'-pentamethoxychalcone | 3.34e-05 | 2 | 132 | 2 | CID005374858 | |
| Drug | 6-chloro-6-deoxyglucitol | 3.34e-05 | 2 | 132 | 2 | CID000131735 | |
| Drug | 5-aminoisatin | 3.34e-05 | 2 | 132 | 2 | CID011819346 | |
| Drug | 3-bromolactate | 3.34e-05 | 2 | 132 | 2 | CID000098978 | |
| Drug | echinone | 3.34e-05 | 2 | 132 | 2 | CID000157629 | |
| Drug | 4-oxonorvaline | 3.34e-05 | 2 | 132 | 2 | CID000000423 | |
| Drug | NSC93767 | 3.42e-05 | 32 | 132 | 4 | CID000005658 | |
| Drug | CHAPS detergent | 3.87e-05 | 158 | 132 | 7 | CID000107670 | |
| Drug | CNS 1145 | 3.88e-05 | 33 | 132 | 4 | CID000190902 | |
| Drug | IHC-64 | 3.88e-05 | 33 | 132 | 4 | CID000162753 | |
| Drug | Tetracaine | 4.03e-05 | 12 | 132 | 3 | ctd:D013748 | |
| Drug | glutamate | GABRD GABRE CACNA1F CACNA2D1 RELN GAPDH GRID1 GRID2 SLC7A11 RYR1 RYR3 SCN9A SCNN1G TRPM8 GAPDHS QARS1 ENPEP | 4.22e-05 | 962 | 132 | 17 | CID000000611 |
| Drug | ADPribulose | 5.22e-05 | 13 | 132 | 3 | CID000197570 | |
| Drug | benzocaine | 6.15e-05 | 37 | 132 | 4 | CID000002337 | |
| Drug | valproate | CACNA1F CACNA2D1 RELN PCDHGC4 SFMBT2 RYR1 RYR3 TGFBR3 SCN9A SCNN1G | 7.82e-05 | 381 | 132 | 10 | CID000003121 |
| Drug | genistein | ROCK2 GABRD GABRE CACNA1F CACNA2D1 GAPDH DSG3 LAMA5 SLC7A11 OLFML3 CLDN1 USP20 RYR1 RYR3 PIK3C2B PIK3C3 GAPDHS MMP16 | 8.12e-05 | 1117 | 132 | 18 | CID005280961 |
| Drug | FPL 64176 | 8.24e-05 | 15 | 132 | 3 | CID000003423 | |
| Drug | NSC7524 | 9.45e-05 | 182 | 132 | 7 | CID000005657 | |
| Drug | Fura-2AM | 9.70e-05 | 79 | 132 | 5 | CID000105091 | |
| Drug | 7-BrMe-12-MeBA | 9.97e-05 | 3 | 132 | 2 | CID000027767 | |
| Drug | sodium perborate | 9.97e-05 | 3 | 132 | 2 | CID000517072 | |
| Drug | cis-diammineplatinum(II | 9.97e-05 | 3 | 132 | 2 | CID000159790 | |
| Drug | 2,4-diaminovaleric acid | 9.97e-05 | 3 | 132 | 2 | CID000000063 | |
| Drug | 2-hydroxyheptanoic acid | 9.97e-05 | 3 | 132 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 9.97e-05 | 3 | 132 | 2 | CID000127713 | |
| Drug | NSC136036 | 9.97e-05 | 3 | 132 | 2 | CID000282522 | |
| Drug | aminodantrolene | 9.97e-05 | 3 | 132 | 2 | CID009570289 | |
| Drug | 2-chloroethyl ethyl sulfone | 9.97e-05 | 3 | 132 | 2 | CID000101406 | |
| Drug | 3-chlorolactaldehyde | 9.97e-05 | 3 | 132 | 2 | CID000129655 | |
| Drug | 2-hydroxycarbazole | 9.97e-05 | 3 | 132 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 9.97e-05 | 3 | 132 | 2 | CID000080262 | |
| Drug | flubendiamide | 9.97e-05 | 3 | 132 | 2 | CID011193251 | |
| Drug | biotinyl-ADP | 9.97e-05 | 3 | 132 | 2 | CID000084080 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 9.97e-05 | 3 | 132 | 2 | CID005748312 | |
| Drug | 7-methoxymethyl-12-methylbenz(a)anthracene | 9.97e-05 | 3 | 132 | 2 | CID000083361 | |
| Drug | 2-chloroethyl ethyl sulfoxide | 9.97e-05 | 3 | 132 | 2 | CID000214273 | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.12e-04 | 187 | 132 | 7 | 4581_UP | |
| Drug | aniracetam | 1.12e-04 | 130 | 132 | 6 | CID000002196 | |
| Drug | sodium | GABRD GABRE ATP8B3 CACNA2D1 GRID1 GRID2 SLC7A7 SLC7A11 RYR1 RYR3 DIPK2A PTPRB SACS SCN9A SCN10A SCNN1G | 1.17e-04 | 944 | 132 | 16 | CID000000923 |
| Drug | methyl acetimidate | 1.22e-04 | 17 | 132 | 3 | CID000026888 | |
| Drug | ApUpG | 1.22e-04 | 17 | 132 | 3 | CID000165128 | |
| Drug | lifarizine | 1.22e-04 | 17 | 132 | 3 | CID000071336 | |
| Drug | baclofen | 1.28e-04 | 191 | 132 | 7 | CID000002284 | |
| Drug | XeC compound | 1.30e-04 | 84 | 132 | 5 | CID000005701 | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 192 | 132 | 7 | 5607_UP | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A | 1.41e-04 | 194 | 132 | 7 | 4643_UP | |
| Drug | lanthanum | 1.44e-04 | 136 | 132 | 6 | CID000023926 | |
| Drug | 1H-imidazole hydrochloride | 1.46e-04 | 18 | 132 | 3 | CID000518985 | |
| Drug | rotenone; Up 200; 1uM; MCF7; HT_HG-U133A | 1.55e-04 | 197 | 132 | 7 | 5915_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.55e-04 | 197 | 132 | 7 | 3698_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 197 | 132 | 7 | 4729_UP | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 132 | 7 | 6525_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 132 | 7 | 4101_UP | |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 132 | 7 | 7446_UP | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 132 | 7 | 5876_DN | |
| Drug | diprafenone | 1.72e-04 | 19 | 132 | 3 | CID000071249 | |
| Drug | indoxacarb | 1.87e-04 | 49 | 132 | 4 | CID000107720 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.89e-04 | 91 | 132 | 5 | CID000002207 | |
| Drug | A-30 | 1.99e-04 | 4 | 132 | 2 | CID003028528 | |
| Drug | Lidocaine | 1.99e-04 | 4 | 132 | 2 | DB00281 | |
| Drug | PCB74 | 1.99e-04 | 4 | 132 | 2 | CID000036218 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.99e-04 | 4 | 132 | 2 | ctd:C501880 | |
| Drug | oxoammonium tetrafluoroborate | 1.99e-04 | 4 | 132 | 2 | CID000151929 | |
| Drug | 3-chlorolactate | 1.99e-04 | 4 | 132 | 2 | CID000092899 | |
| Drug | natrin | 1.99e-04 | 4 | 132 | 2 | CID000019130 | |
| Drug | 148504-47-6 | 1.99e-04 | 4 | 132 | 2 | CID006444275 | |
| Drug | Bastadin 10 | 1.99e-04 | 4 | 132 | 2 | CID009589366 | |
| Drug | SC 38249 | 1.99e-04 | 4 | 132 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 1.99e-04 | 4 | 132 | 2 | CID000035682 | |
| Drug | adenosine diphosphoribose | 1.99e-04 | 92 | 132 | 5 | CID000030243 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.17e-08 | 10 | 129 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.17e-08 | 10 | 129 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.68e-07 | 12 | 129 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 6.73e-06 | 9 | 129 | 3 | C3502809 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.90e-05 | 2 | 129 | 2 | C4551549 | |
| Disease | Neuralgia, Supraorbital | 4.38e-05 | 16 | 129 | 3 | C0038870 | |
| Disease | Neuralgia | 4.38e-05 | 16 | 129 | 3 | C0027796 | |
| Disease | Neuralgia, Atypical | 4.38e-05 | 16 | 129 | 3 | C0234247 | |
| Disease | Neuralgia, Stump | 4.38e-05 | 16 | 129 | 3 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 4.38e-05 | 16 | 129 | 3 | C0423712 | |
| Disease | Neuralgia, Perineal | 4.38e-05 | 16 | 129 | 3 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 4.38e-05 | 16 | 129 | 3 | C0751373 | |
| Disease | Nerve Pain | 4.38e-05 | 16 | 129 | 3 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 4.38e-05 | 16 | 129 | 3 | C0751371 | |
| Disease | Neuralgia, Vidian | 4.38e-05 | 16 | 129 | 3 | C0042656 | |
| Disease | Autosomal dominant epilepsy with auditory features | 5.67e-05 | 3 | 129 | 2 | cv:C1838062 | |
| Disease | B Virus Infection | 5.67e-05 | 3 | 129 | 2 | C0037140 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 5.67e-05 | 3 | 129 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Postherpetic neuralgia | 5.67e-05 | 3 | 129 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 5.67e-05 | 3 | 129 | 2 | C0019372 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 5.67e-05 | 3 | 129 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 | 5.67e-05 | 3 | 129 | 2 | 600512 | |
| Disease | Primary Erythermalgia | 5.67e-05 | 3 | 129 | 2 | C0014805 | |
| Disease | Epilepsy, Familial Temporal Lobe 1 | 5.67e-05 | 3 | 129 | 2 | C4551957 | |
| Disease | Epilepsy, familial temporal lobe, 1 | 5.67e-05 | 3 | 129 | 2 | cv:C4551957 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 5.67e-05 | 3 | 129 | 2 | C1833661 | |
| Disease | Autosomal Dominant Lateral Temporal Lobe Epilepsy | 5.67e-05 | 3 | 129 | 2 | C1838062 | |
| Disease | epilepsy (implicated_via_orthology) | 8.42e-05 | 163 | 129 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Jeune thoracic dystrophy | 1.13e-04 | 4 | 129 | 2 | cv:C0265275 | |
| Disease | cutaneous melanoma, hair color | 1.60e-04 | 62 | 129 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | Sudden death | 1.88e-04 | 5 | 129 | 2 | C0011071 | |
| Disease | Colorectal Carcinoma | GAPDH ABCA13 OTOP2 GRID1 GRID2 F5 SACS ARHGEF1 GNB5 SCNN1G CNTN1 | 2.68e-04 | 702 | 129 | 11 | C0009402 |
| Disease | Cone-Rod Dystrophy 2 | 2.74e-04 | 29 | 129 | 3 | C3489532 | |
| Disease | Disorder of eye | 3.50e-04 | 212 | 129 | 6 | C0015397 | |
| Disease | Congenital Pain Insensitivity | 3.93e-04 | 7 | 129 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 3.93e-04 | 7 | 129 | 2 | C0020075 | |
| Disease | Albinism, Oculocutaneous | 3.93e-04 | 7 | 129 | 2 | C0078918 | |
| Disease | eye colour measurement | 4.06e-04 | 218 | 129 | 6 | EFO_0009764 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 5.22e-04 | 8 | 129 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 5.22e-04 | 8 | 129 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 5.22e-04 | 8 | 129 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 5.22e-04 | 8 | 129 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 5.22e-04 | 8 | 129 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 5.22e-04 | 8 | 129 | 2 | C0393703 | |
| Disease | Autism Spectrum Disorders | 5.37e-04 | 85 | 129 | 4 | C1510586 | |
| Disease | glaucoma | 5.94e-04 | 154 | 129 | 5 | MONDO_0005041 | |
| Disease | Myoclonic Epilepsy | 6.69e-04 | 9 | 129 | 2 | C0014550 | |
| Disease | Inherited neuropathies | 7.17e-04 | 40 | 129 | 3 | C0598589 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 8.05e-04 | 447 | 129 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Epilepsy, Myoclonic, Infantile | 8.34e-04 | 10 | 129 | 2 | C0917800 | |
| Disease | Other specified cardiac arrhythmias | 1.02e-03 | 11 | 129 | 2 | C0348626 | |
| Disease | Jeune thoracic dystrophy | 1.02e-03 | 11 | 129 | 2 | C0265275 | |
| Disease | Nodal rhythm disorder | 1.02e-03 | 11 | 129 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 1.02e-03 | 11 | 129 | 2 | C1399226 | |
| Disease | Shortened QT interval | 1.02e-03 | 11 | 129 | 2 | C0151879 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 1.02e-03 | 11 | 129 | 2 | C2748542 | |
| Disease | Myoclonic Astatic Epilepsy | 1.02e-03 | 11 | 129 | 2 | C0393702 | |
| Disease | systolic blood pressure change measurement | 1.15e-03 | 47 | 129 | 3 | EFO_0006944 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.22e-03 | 12 | 129 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.22e-03 | 12 | 129 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.22e-03 | 12 | 129 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.22e-03 | 12 | 129 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.22e-03 | 12 | 129 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.22e-03 | 12 | 129 | 2 | C1848172 | |
| Disease | Ciliopathies | 1.41e-03 | 110 | 129 | 4 | C4277690 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.43e-03 | 13 | 129 | 2 | C0751122 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.43e-03 | 13 | 129 | 2 | C4041558 | |
| Disease | Brugada Syndrome 1 | 1.43e-03 | 13 | 129 | 2 | C4551804 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.43e-03 | 13 | 129 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | Uveal Melanoma | 1.63e-03 | 53 | 129 | 3 | EFO_1000616 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.92e-03 | 15 | 129 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Sinus Node Dysfunction (disorder) | 1.92e-03 | 15 | 129 | 2 | C0428908 | |
| Disease | Night blindness, congenital stationary | 2.47e-03 | 17 | 129 | 2 | C0339535 | |
| Disease | age at onset, Parkinson disease | 2.77e-03 | 18 | 129 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | Headache | 2.80e-03 | 64 | 129 | 3 | HP_0002315 | |
| Disease | skin pigmentation measurement | 3.13e-03 | 137 | 129 | 4 | EFO_0007009 | |
| Disease | diet measurement, body mass index | 3.42e-03 | 20 | 129 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | alpha-tocopherol measurement | 3.42e-03 | 20 | 129 | 2 | EFO_0007898 | |
| Disease | nucleotide measurement | 4.06e-03 | 73 | 129 | 3 | EFO_0010513 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.14e-03 | 22 | 129 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | otitis media (implicated_via_orthology) | 4.14e-03 | 22 | 129 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | Bronchiectasis | 4.14e-03 | 22 | 129 | 2 | C0006267 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEDYSAEYIIQQGGW | 186 | Q9BXK5 | |
| FQVAERALYFWNNEY | 371 | Q15173 | |
| KFVDTDIWNQYLEYQ | 81 | Q9H993 | |
| WDLSYESINYIFASD | 321 | Q6DHV7 | |
| YVLFTWDQEAQIYEL | 726 | Q92888 | |
| TYSDYLRWESFLQQQ | 1136 | Q9P2K9 | |
| AYNQVWEECYSQVLY | 656 | Q99459 | |
| SWNTYYSNTEFIILV | 76 | Q96KC2 | |
| DITWVQTYEEGLFYA | 41 | Q8TD06 | |
| TLEKTQFFLEQAYYW | 626 | Q86UQ4 | |
| FIYLGNSVFIDWDVQ | 451 | O60423 | |
| SSYQGYPEAEVFWQD | 166 | Q5ZPR3 | |
| FSATANQWEIYDAYV | 221 | Q9UI46 | |
| EYYWDQLNETVFTVH | 1046 | Q9C0C7 | |
| IQSWYDEILDFVYGV | 111 | P16562 | |
| VEPWKEQFFESYYGQ | 366 | Q76L83 | |
| AQTAYEDWFITLYNV | 976 | O43520 | |
| FQIGLDTSYWTFVNA | 1086 | O43520 | |
| LAYYDSNVDLFTWGT | 1191 | O60312 | |
| YVQVTSNFLYATEIW | 1096 | Q9UHB7 | |
| DFYEQNSRYQLTLWG | 636 | P54802 | |
| TNYQSFENLEDWYTV | 96 | P51157 | |
| FAGYNDYTINVWDVL | 341 | O14775 | |
| WDYDFLIYDGVIDNT | 266 | Q86VS3 | |
| ERQLYAWDDGYQIVY | 381 | Q9NRN5 | |
| SYGWEILDEFYNVKF | 121 | Q03112 | |
| QYENVFIFETGYWLT | 256 | Q7Z5J8 | |
| YEYTLGQAQNLIIFW | 66 | Q9P2P5 | |
| YRVWATVNSAAFEYL | 1181 | O60840 | |
| EYTDNWLAVYFFTSG | 296 | P32926 | |
| DYELQQFYEVAVVAW | 496 | Q8N6Y1 | |
| TASEGELSWYNIFLY | 1106 | P23467 | |
| WVDLYLDYVGVVDYQ | 386 | Q9NZR2 | |
| LIFDSGVDLNYSYAW | 491 | Q9UPQ8 | |
| WGVNTYVTQVSFTYD | 1756 | Q2M2H8 | |
| WNYETNTLELFKEYQ | 416 | Q96MR6 | |
| NYAFVWDAAVLEYVA | 736 | O43424 | |
| AADVYAFGTVWYELQ | 801 | Q8IVT5 | |
| FSQEIEYWGINEFFI | 101 | Q9ULS6 | |
| GEQTITTLYTNWYLE | 781 | P55160 | |
| AFVSSLIYNWEGEYF | 566 | Q9UBG0 | |
| GYSSEDIVYYWSESQ | 186 | O14764 | |
| YTIDIIFSQTWYDER | 116 | P78334 | |
| VELQYLWVTYNSVAS | 81 | Q3SXY7 | |
| FYRVNYEVATWDSIA | 626 | Q07075 | |
| FYSNATGVWLYVDDQ | 3206 | O15230 | |
| VDLDSGYNAWVSYQL | 596 | Q9Y5F7 | |
| DNSVDVYAFGILFWY | 826 | Q6XUX3 | |
| VQYSTDFGVSWNYLV | 2776 | P78509 | |
| DTALAIIYNLWFGYD | 136 | B5MD39 | |
| DIQDYFLTGYVWSAV | 351 | O00750 | |
| NTVEVDFYGYSLWAV | 521 | Q7RTS6 | |
| EGSRFDLNDVYVYWQ | 41 | O75144 | |
| LQVGEEVWLAVNDYY | 211 | P02747 | |
| EYRNNLENWIGDYFE | 2136 | Q8NCM8 | |
| VLTYQGFYDENLEWV | 2381 | Q8NCM8 | |
| QYFNSFIDEYIVLWI | 361 | Q9Y6K0 | |
| VVGWTVNTFDEKSYY | 296 | Q9NZC3 | |
| EVIEWLGAYYIDTQF | 621 | Q13099 | |
| EQYHSLNEIYSWIEF | 121 | Q96IY4 | |
| ATAWYGNRIVQEFYD | 136 | O95832 | |
| NWQENPETYEDSFYK | 751 | P54289 | |
| AVNYVGEELWSYFNA | 241 | Q8NDZ4 | |
| LTFVWSFNGYVIDFN | 536 | Q12860 | |
| DTTEVNDYYLWSIFN | 146 | A6NMD0 | |
| LTNLWYTGQITNFEY | 3131 | Q99698 | |
| TTAGWNYLLEQYELS | 801 | Q6P179 | |
| NYAFLWDVAVVEYAA | 736 | Q9ULK0 | |
| YVWGGYVSIEDNEVY | 26 | Q8N7A1 | |
| FLVSNSGDYEILYWV | 686 | O00423 | |
| NLVEADYSYWTLAYV | 486 | Q8NBJ5 | |
| EYQESSYFSQFLQWK | 161 | P32298 | |
| NDNFVKLISWYDNEY | 376 | O14556 | |
| FIQATDYVEIWQAYL | 411 | Q15020 | |
| TEYKQFWDVDLGVTY | 556 | Q9UPN6 | |
| TYTFSSGINAIQEWY | 216 | P51170 | |
| FLYDETQYGTETLWS | 131 | Q9NZJ4 | |
| YQIWKFGVIFTDNSF | 4776 | P21817 | |
| YDNPVTSVFQYEGLW | 36 | P56856 | |
| YVRSGWDNYEFDINE | 336 | Q9BQ95 | |
| SLWALLQQEEYVYFS | 186 | Q0P6D2 | |
| QLLSSYQFYWGVEEQ | 836 | A6NKG5 | |
| SDYFDQLYAWAVELI | 336 | P47897 | |
| IEYISYFWVIGNQSS | 81 | Q9NYW0 | |
| WYATVFNSALYGLEV | 66 | P59542 | |
| WYATQLNPAFYSVEV | 66 | P59541 | |
| QDLQGEVEYYTLFWS | 2951 | O75445 | |
| DAFYYENNLWILIEF | 96 | Q9H2G2 | |
| NYYIAAEEISWDYSE | 1581 | P12259 | |
| FQTYFTQDYAQTAWI | 76 | Q6ZSM3 | |
| ISWYDNEFGYSNRVV | 311 | P04406 | |
| NSTLANYLYWYVIVE | 486 | Q8NEB9 | |
| FSYPVISYWVDSQDQ | 631 | Q9H3S1 | |
| TRNEWYDFYLISQVA | 761 | Q7Z3Z4 | |
| YEYFQVGWNIFDSLI | 801 | Q15858 | |
| YSWQDLVASGVVEYI | 651 | P30876 | |
| WNETTTSVYQYLGFQ | 6 | P0DKX4 | |
| RLWTDQYEEAFTNQY | 211 | Q9C0A6 | |
| WYDGEFLYSFTIDNS | 106 | Q92185 | |
| PWSNFSFVVEYNYVE | 806 | Q5VXU9 | |
| TDFYTTVNNYWILNA | 216 | Q75T13 | |
| GTDTGVVQYFYIEDW | 491 | Q8NEZ3 | |
| VVQYFYIEDWQFVND | 496 | Q8NEZ3 | |
| TQGYLVWFEPYQEES | 576 | Q96JS3 | |
| YYFQEGWNIFDGFIV | 826 | P35498 | |
| QVAERALYFWNNEYI | 366 | Q15172 | |
| QYNWLSYEDVFVRAF | 131 | O95573 | |
| GDWTYEEQFKQLYEL | 221 | Q99856 | |
| YDFVPDWAEILYQQV | 2341 | Q96JI7 | |
| YAGWFYLNFVTEEVE | 246 | Q9UPY5 | |
| TPQFENISIYNYFVW | 176 | P17643 | |
| EQSVFYWEQVTDGFF | 366 | O60858 | |
| IFSAIWENQFYYLFG | 521 | Q92544 | |
| GTEQYFNVEVWLQKY | 36 | P51512 | |
| QVFLDGNEVYVWIYD | 176 | Q99442 | |
| GYFSQYVAWVREEVT | 736 | Q8N271 | |
| GYQRFWIETEEYSFE | 3511 | Q15413 | |
| RQYYFTNGWNVFDFI | 1531 | Q9Y5Y9 | |
| LFSYSGWDTLNYVTE | 236 | Q9UM01 | |
| VGLEDTESYDQWLFY | 221 | Q5VUG0 | |
| YISDVYDFQKQAWFT | 841 | Q9HBJ7 | |
| VLGIIYDNQVYWYEG | 186 | Q71RS6 | |
| WVVQLFYAFQDDRYL | 151 | O75116 | |
| DWEEYINNKTNFYTV | 301 | Q9UQD0 | |
| YYFQEGWNIFDGFIV | 811 | Q9UQD0 | |
| YYFDVAEVEAWLGEQ | 1626 | Q9H254 | |
| SYAAQGWLAFIVEYI | 506 | Q9Y2K6 | |
| VINGQWYEFDDQYVT | 651 | Q9Y2K6 | |
| GQISEETWTYLNSLY | 866 | Q9Y2K6 | |
| SNYTDWFEVYNATRV | 151 | O14817 | |
| DEVRQWYVNGVNYFT | 781 | Q7Z2W7 | |
| TWYNIFLVYNEERTF | 186 | Q96HH4 | |
| IYFFDQIDELPTYWS | 1211 | Q5VYS8 | |
| YESVKYIQQENFWVG | 446 | Q6PJF5 | |
| TWIFPAEYTQFQNYV | 131 | Q6ZT98 | |
| WSALDGVVYYNSIVI | 511 | Q03167 | |
| TIQAIGITYFYKEEW | 66 | Q5FWF4 | |
| ILGSDYSFTQVYNWD | 491 | O95970 | |
| YDVDTENFVRYWQQA | 541 | O94898 | |
| YWQQAGEALEYTSIL | 551 | O94898 | |
| YEAEGIAWEPVQYFN | 461 | O00159 |